Table 1.
Pancreatic cancer incidence rates.
Table 2.
Baseline characteristics, and univariate and multivariable analyses in men.
Table 3.
Baseline characteristics, and univariate and multivariable analyses in women.
Table 4.
Baseline characteristics in the validation cohort.
Fig 1.
Discrimination and calibration ability of the pancreatic cancer prediction model in men as assessed in an external validation set (n = 500,046, events = 711).
(A) discrimination ability and (B) calibration ability.
Fig 2.
Discrimination and calibration ability of the pancreatic cancer prediction model in women as assessed in an external validation set (n = 627,629, events = 576).
(A) discrimination ability and (B) calibration ability.
Fig 3.
Cumulative incidence probability for five risk groups.
(A) men and (B) women.